Do KA - Search Results

1

Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Kebriaei P, Singh H, Huls MH, Figliola MJ, Bassett R, Olivares S, Jena B, Dawson MJ, Kumaresan PR, Su S, Maiti S, Dai J, Moriarity B, Forget MA, Senyukov V, Orozco A, Liu T, McCarty J, Jackson RN, Moyes JS, Rondon G, Qazilbash M, Ciurea S, Alousi A, Nieto Y, Rezvani K, Marin D, Popat U, Hosing C, Shpall EJ, Kantarjian H, Keating M, Wierda W, Do KA, Largaespada DA, Lee DA, Hackett PB, Champlin RE, Cooper LJ. Kebriaei P, et al. Among authors: do ka. J Clin Invest. 2016 Sep 1;126(9):3363-76. doi: 10.1172/JCI86721. Epub 2016 Aug 2. J Clin Invest. 2016. PMID: 27482888 Free PMC article. Clinical Trial.

2

Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.

Giles FJ, Vose JM, Do KA, Johnson MM, Manshouri T, Bociek G, Bierman PJ, O'Brien SM, Keating MJ, Kantarjian HM, Armitage JO, Albitar M. Giles FJ, et al. Among authors: do ka. Br J Haematol. 2003 Dec;123(5):850-7. doi: 10.1046/j.1365-2141.2003.04683.x. Br J Haematol. 2003. PMID: 14632776 Free article.

3

Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone.

Tsimberidou AM, Catovsky D, Schlette E, O'Brien S, Wierda WG, Kantarjian H, Garcia-Manero G, Wen S, Do KA, Lerner S, Keating MJ. Tsimberidou AM, et al. Among authors: do ka. Cancer. 2006 Jul 1;107(1):125-35. doi: 10.1002/cncr.21931. Cancer. 2006. PMID: 16700034 Free article.

4

Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation.

Tsimberidou AM, O'Brien S, Khouri I, Giles FJ, Kantarjian HM, Champlin R, Wen S, Do KA, Smith SC, Lerner S, Freireich EJ, Keating MJ. Tsimberidou AM, et al. Among authors: do ka. J Clin Oncol. 2006 May 20;24(15):2343-51. doi: 10.1200/JCO.2005.05.0187. J Clin Oncol. 2006. PMID: 16710033

5

Assessment of chronic lymphocytic leukemia and small lymphocytic lymphoma by absolute lymphocyte counts in 2,126 patients: 20 years of experience at the University of Texas M.D. Anderson Cancer Center.

Tsimberidou AM, Wen S, O'Brien S, McLaughlin P, Wierda WG, Ferrajoli A, Faderl S, Manning J, Lerner S, Mai CV, Rodriguez AM, Hess M, Do KA, Freireich EJ, Kantarjian HM, Medeiros LJ, Keating MJ. Tsimberidou AM, et al. Among authors: do ka. J Clin Oncol. 2007 Oct 10;25(29):4648-56. doi: 10.1200/JCO.2006.09.4508. J Clin Oncol. 2007. PMID: 17925562

6

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia.

Tam CS, O'Brien S, Wierda W, Kantarjian H, Wen S, Do KA, Thomas DA, Cortes J, Lerner S, Keating MJ. Tam CS, et al. Among authors: do ka. Blood. 2008 Aug 15;112(4):975-80. doi: 10.1182/blood-2008-02-140582. Epub 2008 Apr 14. Blood. 2008. PMID: 18411418 Free PMC article. Clinical Trial.

7

Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.

Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Garcia-Manero G, Cortes J, Thomas D, Koller C, Burger J, Lerner S, Kantarjian H, Keating M. Wierda WG, et al. Among authors: do ka. J Clin Oncol. 2009 Apr 1;27(10):1637-43. doi: 10.1200/JCO.2008.18.1701. Epub 2009 Feb 17. J Clin Oncol. 2009. PMID: 19224852 Free PMC article.

8

Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab).

Tam CS, O'Brien S, Plunkett W, Wierda W, Ferrajoli A, Wang X, Do KA, Cortes J, Khouri I, Kantarjian H, Lerner S, Keating MJ. Tam CS, et al. Among authors: do ka. Blood. 2014 Nov 13;124(20):3059-64. doi: 10.1182/blood-2014-06-583765. Epub 2014 Oct 3. Blood. 2014. PMID: 25281606 Free PMC article.

9

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.

Caruso HG, Torikai H, Zhang L, Maiti S, Dai J, Do KA, Singh H, Huls H, Lee DA, Champlin RE, Heimberger AB, Cooper LJ. Caruso HG, et al. Among authors: do ka. J Immunother. 2016 Jun;39(5):205-17. doi: 10.1097/CJI.0000000000000126. J Immunother. 2016. PMID: 27163741 Free PMC article.

10

Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.

Manshouri T, Do KA, Wang X, Giles FJ, O'Brien SM, Saffer H, Thomas D, Jilani I, Kantarjian HM, Keating MJ, Albitar M. Manshouri T, et al. Among authors: do ka. Blood. 2003 Apr 1;101(7):2507-13. doi: 10.1182/blood-2002-06-1639. Epub 2002 Nov 21. Blood. 2003. PMID: 12446458 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page